Ex-vivo thrombolytic gene therapy for vein graft patency: the frontier for development of selective, localised therapeutic approaches.
Hagemeyer
Christoph E
CE
Peter
Karlheinz
K
D050197:Atherosclerosis / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D006083:Graft Occlusion, Vascular / Q000628:therapy*; D006801:Humans; D015912:Thrombolytic Therapy / Q000379:methods / Q000639:trends*; D013927:Thrombosis / Q000628:therapy*; D014654:Vascular Patency